References
- Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 2009; 48: 1033–1041.
- Ogawa MM, Galante NZ, Godoy P, . Treatment of subcutaneous phaeohyphomycosis and prospective follow-up of 17 kidney transplant recipients. J Am Acad Dermatol 2009; 61: 977–985.
- Pastor FJ, Guarro J. Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect 2008; 14: 734–746.
- Mori T, Aisa Y, Kato J, . Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole. Int J Hematol 2009; 90: 103–107.
- Andersen B, Sørensen JL, Nielsen KF, Gerrits van den Ende B, de Hoog S. A polyphasic approach to the taxonomy of the Alternaria infectoria species-group. Fungal Genet Biol 2009; 46: 642–656.
- Proia LA, Trenholme GM. Chronic refractory phaeohyphomycosis: successful treatment with posaconazole. Mycoses 2006; 49: 519–522.
- Boyce RD, Deziel PJ, Otley CC, . Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis 2010; 12: 242–250.
- Vermeire SEM, de Jonge H, Lagrou K, Kuypers DRJ. Cutaneous phaeohyphomycosis in renal allograft recipients: report of 2 cases and review of the literature. Diagn Microbiol Infect Dis 2010; 68: 177–180.
- Segner S, Jouret F, Durant J-F, Marot L, Kanaan N. Cutaneous infection by Alternaria infectoria in a renal transplant patient. Transpl Infect Dis 2009; 11: 330–332.
- Lipp H-P. Posaconazole: clinical pharmacokinetics and drug interactions. Mycoses 2011; 54,(Suppl. 1): 32–38.
- Krishna G, Beresford E, Ma L, . Skin concentrations and pharmacokinetics of posaconazole after oral administration. Antimicrob Agents Chemother 2010; 54: 1807–1810.
- Raad II, Graybill JR, Bustamante AB, . Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis 2006; 42: 1726–1734.
- Badali H, de Hoog GS, Curfs-Breuker I, . Use of amplified fragment length polymorphism to identify 42 Cladophialophora strains related to cerebral phaeohyphomycosis with in vitro antifungal susceptibility. J Clin Microbiol 2010; 48: 2350–2356.
- Cristini A, Garcia-Hermoso D, Celard M, Albrand G, Lortholary O. Cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei in a woman native to Afghanistan. J Clin Microbiol 2010; 48: 3451–3454.
- González GM. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi. Med Mycol 2009; 47: 71–76.